Use of the new levodopa agent Stalevo (levodopa/carbidopa/entacapone) in the treatment of Parkinson's disease in out-patient clinical practice (the START-M open trial).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples